DEXCOM, INC. (DXCM) Current Ratio
- Current ratio · latest quarter: Value 1.73×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.73× | Current assets / current liabilities. $4.09B ÷ $2.36B ≈ 1.73× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 4.09B USD | Assets, Current |
| Current obligations | 2.36B USD | Liabilities, Current |
| Cash and equivalents | 1.10B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 1.26B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 726.40M USD | Inventory, Net |
| Payables | (m) | |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.09B | $2.36B | $1.10B | (m) | $1.26B | $726.40M | (m) | (m) | 1.73× |
| 2026-03-31 | $4.33B | $2.22B | $1.12B | (m) | $1.09B | $693.60M | (m) | (m) | 1.95× |
| 2025-12-31 | $4.03B | $2.14B | $917.70M | (m) | $1.22B | $629.10M | (m) | (m) | 1.88× |
| 2025-09-30 | $5.22B | $3.34B | $1.84B | (m) | $1.11B | $604.10M | (m) | (m) | 1.56× |
| 2025-06-30 | $5.03B | $3.31B | $1.16B | (m) | $1.35B | $570.70M | (m) | (m) | 1.52× |
| 2025-03-31 | $4.55B | $3.04B | $904.90M | $1.56B | $1.16B | $538.20M | (m) | (m) | 1.50× |
| 2024-12-31 | $4.30B | $2.93B | $606.10M | (m) | $1.01B | $542.60M | (m) | (m) | 1.47× |
| 2024-09-30 | $4.26B | $1.73B | $621.20M | $1.65B | $1.00B | $586.30M | (m) | (m) | 2.46× |
| 2024-06-30 | $4.85B | $1.72B | $939.20M | $2.03B | $945.20M | $570.30M | (m) | (m) | 2.82× |
| 2024-03-31 | $4.62B | $1.59B | $851.20M | $1.77B | $978.60M | $589.10M | (m) | (m) | 2.90× |
| 2023-12-31 | $4.43B | $1.56B | $566.30M | $2.16B | $973.90M | $559.60M | (m) | (m) | 2.84× |
| 2023-09-30 | $4.70B | $1.68B | $643.70M | $2.60B | $785.70M | $498.60M | (m) | (m) | 2.80× |
| 2023-06-30 | $5.00B | $2.07B | $1.19B | $2.44B | $750.60M | $421.10M | (m) | (m) | 2.42× |
| 2023-03-31 | $3.77B | $1.86B | $623.20M | $1.94B | $636.80M | $366.00M | (m) | (m) | 2.02× |
| 2022-12-31 | $3.67B | $1.84B | $642.30M | $1.81B | $713.30M | $306.70M | (m) | (m) | 1.99× |
| 2022-09-30 | $3.40B | $900.50M | $698.10M | $1.67B | $564.10M | $311.00M | (m) | (m) | 3.77× |
| 2022-06-30 | $3.81B | $807.00M | $735.40M | $2.02B | $560.80M | $339.50M | (m) | (m) | 4.72× |
| 2022-03-31 | $3.75B | $711.40M | $716.00M | $1.87B | $544.50M | $342.20M | (m) | (m) | 5.27× |
| 2021-12-31 | $3.68B | $720.80M | $1.05B | $1.36B | $514.30M | $357.30M | (m) | (m) | 5.11× |
| 2021-09-30 | $3.66B | $734.90M | $1.44B | $1.08B | $529.10M | $351.30M | (m) | (m) | 4.98× |
| 2021-06-30 | $3.47B | $600.70M | $1.16B | (m) | $483.50M | $319.30M | (m) | (m) | 5.78× |
| 2021-03-31 | $3.45B | $604.10M | $733.80M | (m) | $443.40M | $289.70M | (m) | (m) | 5.70× |
| 2020-12-31 | $3.42B | $614.10M | $817.60M | (m) | $428.50M | $234.70M | (m) | (m) | 5.58× |
| 2020-09-30 | $3.24B | $506.40M | $673.50M | (m) | $370.00M | $200.70M | (m) | (m) | 6.39× |
| 2020-06-30 | $3.03B | $400.10M | $530.00M | (m) | $296.50M | $165.30M | (m) | (m) | 7.58× |
| 2020-03-31 | $2.00B | $342.80M | $584.60M | (m) | $300.70M | $141.90M | (m) | (m) | 5.82× |
| 2019-12-31 | $1.97B | $360.20M | $446.20M | (m) | $286.30M | $119.80M | (m) | (m) | 5.47× |
| 2019-09-30 | $1.82B | $322.40M | $395.60M | (m) | $234.90M | $120.40M | (m) | (m) | 5.63× |
| 2019-06-30 | $1.74B | $288.20M | $709.20M | (m) | $217.30M | $117.90M | (m) | (m) | 6.05× |
| 2019-03-31 | $1.69B | $235.40M | $1.29B | (m) | $204.70M | $101.10M | (m) | (m) | 7.18× |
| 2018-12-31 | $1.70B | $222.40M | $1.14B | (m) | $226.70M | $70.70M | (m) | (m) | 7.64× |
| 2018-09-30 | $914.10M | $193.90M | $367.40M | $258.50M | $169.80M | $55.20M | (m) | (m) | 4.71× |
| 2018-06-30 | $836.00M | $170.80M | $300.20M | $250.80M | $162.00M | $46.20M | (m) | (m) | 4.89× |
| 2018-03-31 | $729.30M | $125.10M | $420.40M | $101.10M | $123.90M | $51.60M | (m) | (m) | 5.83× |
| 2017-12-31 | $744.70M | $138.90M | $441.50M | (m) | $134.30M | $45.20M | (m) | (m) | 5.36× |
| 2017-09-30 | $692.90M | $118.20M | $402.10M | $123.70M | $110.50M | $43.30M | (m) | (m) | 5.86× |
| 2017-06-30 | $656.80M | $105.10M | $395.90M | $100.70M | $101.70M | $42.80M | (m) | (m) | 6.25× |
| 2017-03-31 | $330.50M | $171.70M | $153.50M | $27.60M | $85.90M | $46.50M | (m) | (m) | 1.92× |
| 2016-12-31 | $280.00M | $102.40M | $94.50M | $29.20M | $101.70M | $45.40M | (m) | (m) | 2.73× |
| 2016-09-30 | $258.60M | $86.10M | $97.70M | $29.60M | $76.80M | $44.70M | (m) | (m) | 3.00× |
| 2016-06-30 | $241.00M | $73.90M | $87.50M | $28.10M | $73.80M | $42.90M | (m) | (m) | 3.26× |
| 2016-03-31 | $227.40M | $64.10M | $77.90M | $28.60M | $67.30M | $46.10M | (m) | (m) | 3.55× |
| 2015-12-31 | $231.30M | $66.90M | $86.10M | $29.10M | $74.10M | $35.20M | (m) | (m) | 3.46× |
| 2015-09-30 | $203.70M | $58.80M | $85.30M | $28.00M | (m) | $30.60M | (m) | (m) | 3.46× |
| 2015-06-30 | $170.40M | $44.20M | $67.70M | $29.80M | (m) | $22.40M | (m) | (m) | 3.86× |
| 2015-03-31 | $146.20M | $37.00M | $54.20M | $29.60M | (m) | $18.40M | (m) | (m) | 3.95× |
| 2014-12-31 | $145.90M | $40.60M | $71.80M | $11.80M | $42.40M | $16.00M | (m) | (m) | 3.59× |
| 2014-09-30 | $123.40M | $40.60M | $63.20M | $11.70M | (m) | $14.30M | (m) | (m) | 3.04× |
| 2014-06-30 | $105.50M | $35.60M | $49.50M | $11.80M | (m) | $11.60M | (m) | (m) | 2.96× |
| 2014-03-31 | $93.60M | $29.70M | $45.70M | $11.70M | (m) | $8.90M | (m) | (m) | 3.15× |
| 2013-12-31 | $93.10M | $32.10M | $43.20M | $11.40M | (m) | $9.00M | (m) | (m) | 2.90× |
| 2013-09-30 | $81.70M | $27.40M | $33.40M | $14.20M | (m) | $10.00M | (m) | (m) | 2.98× |
| 2013-06-30 | $74.20M | $21.10M | $28.20M | $18.20M | (m) | $7.30M | (m) | (m) | 3.52× |
| 2013-03-31 | $71.30M | $16.20M | $18.90M | $26.40M | (m) | $7.50M | (m) | (m) | 4.40× |
| 2012-12-31 | $77.60M | $19.50M | $8.10M | $40.60M | (m) | $7.40M | (m) | (m) | 3.98× |
| 2012-09-30 | $75.57M | $20.40M | $4.74M | $48.64M | (m) | $7.14M | (m) | (m) | 3.70× |
| 2012-06-30 | $83.99M | $16.96M | $5.99M | $55.20M | (m) | $7.38M | (m) | (m) | 4.95× |
| 2012-03-31 | $92.82M | $16.08M | $5.12M | $65.06M | (m) | $8.04M | (m) | (m) | 5.77× |
| 2011-12-31 | $104.50M | $14.70M | $2.60M | $79.40M | (m) | $8.20M | (m) | (m) | 7.11× |
| 2011-09-30 | $115.23M | $14.74M | $17.52M | $79.79M | (m) | $6.46M | (m) | (m) | 7.82× |
| 2011-06-30 | $123.98M | $13.78M | $33.89M | $71.14M | (m) | $6.26M | (m) | (m) | 9.00× |
| 2010-12-31 | $65.36M | $15.13M | $4.89M | $42.22M | (m) | $8.11M | (m) | (m) | 4.32× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |